Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for OptimizeRx (OPRX) over the last 15 years, with Q3 2025 value amounting to 0.01%.

  • OptimizeRx's Return on Capital Employed rose 500.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.09% for FY2024, which is 1000.0% up from last year.
  • Latest data reveals that OptimizeRx reported Return on Capital Employed of 0.01% as of Q3 2025, which was up 500.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Return on Capital Employed registered a high of 0.01% during Q3 2025, and its lowest value of 0.05% during Q4 2023.
  • In the last 5 years, OptimizeRx's Return on Capital Employed had a median value of 0.02% in 2022 and averaged 0.02%.
  • Per our database at Business Quant, OptimizeRx's Return on Capital Employed plummeted by -300bps in 2023 and then surged by 500bps in 2025.
  • Over the past 5 years, OptimizeRx's Return on Capital Employed (Quarter) stood at 0.0% in 2021, then tumbled by -3097bps to 0.02% in 2022, then crashed by -128bps to 0.05% in 2023, then soared by 60bps to 0.02% in 2024, then skyrocketed by 150bps to 0.01% in 2025.
  • Its Return on Capital Employed was 0.01% in Q3 2025, compared to 0.01% in Q2 2025 and 0.02% in Q1 2025.